Skip to content

Eczema and dry skin – observational analysis of patients prescription patterns and healthcare utilization

Eczema and dry skin – observational analysis of patients prescription patterns and healthcare utilization: a retrospective observational cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN91126037
Enrollment
1570
Registered
2017-07-19
Start date
2008-01-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry skin and/or eczema Skin and Connective Tissue Diseases

Interventions

All patients with dry skin and/or eczema in 2008 and 2012 will be identified. Of those, patients with at least 2 distinct emollient prescriptions within 6 months of index will be identified and includ

Sponsors

Johnson & Johnson Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with dry skin and/or eczema in 2008 and 2012 2. Exposed cohort: patients with at least 2 distinct emollient prescriptions within 6 months of index 3. Control cohort: patients with 2 healthcare exposures (visits or prescriptions) for dry skin and/or eczema in 6 months but no emollient prescriptions at any time 4. Continuous = 12 months of medical history prior to diagnosis (washout period) and = 24 months post dry skin and/or eczema diagnosis. The index date will be the date of dry skin and/or eczema diagnosis in those patients with at least 12 months washout period (i.e., first diagnosis in at least 12 months – this constitutes the “clean” period)

Exclusion criteria

Exclusion criteria: 1. Patients with concurrent skin diseases that are typically treated with topical corticosteroids (TCS) such as bullous pemphigoid, lupus, lichen planus, granuloma annulare, lichen sclerosis, alopecia areata and vitiligo 2. Patients with low-quality records or non-continuous data coverage 3. A diagnosis of dry skin-eczema during the washout period (12 months period prior to index diagnosis)

Design outcomes

Secondary

MeasureTime frame
Measured using CPRD database over a two year period from initial diagnosis (post-index): 1. Percentage of patients treated with potent or very potent topical corticosteroids 2. Percentage of patients treated with antimicrobials and/or antibiotics

Primary

MeasureTime frame
Measured using CPRD database over a two year period from initial diagnosis (post-index): 1. Health care utilisation: 1.1 Frequency of GP visits 1.2. Prescriptions for dry skin and eczema

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026